Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen

CONTEXT: The growth inhibitory effect of tamoxifen, which is used for the treatment of hormone receptor–positive breast cancer, is mediated by its metabolites, 4-hydroxytamoxifen and endoxifen. The formation of active metabolites is catalyzed by the polymorphic cytochrome P450 2D6 (CYP2D6) enzyme. O...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schroth, Werner, Goetz, Matthew P., Hamann, Ute, Fasching, Peter A., Schmidt, Marcus, Winter, Stefan, Fritz, Peter, Simon, Wolfgang, Suman, Vera J., Ames, Matthew M., Safgren, Stephanie L., Kuffel, Mary J., Ulmer, Hans Ulrich, Boländer, Julia, Strick, Reiner, Beckmann, Matthias W., Koelbl, Heinz, Weinshilboum, Richard M., Ingle, James N., Eichelbaum, Michel, Schwab, Matthias, Brauch, Hiltrud
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3909953/
https://ncbi.nlm.nih.gov/pubmed/19809024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2009.1420
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados